Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Hair loss in Androgenetic Alopecia is caused by genetics, aging, and lifestyle, leading to hair follicle shrinkage and related health risks.

Clascoterone may be a promising treatment for hair loss.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Using platelet-rich plasma in hair restoration surgery significantly improves hair density after 6 months and is safe to use.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Clascoterone may be an effective topical treatment for hair loss.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.

The conclusion is that obesity should be managed with a slow, balanced approach to diet and exercise, with medication and surgery as additional options, and education and access to care are important.

Old psychiatric drugs are increasingly being used for new purposes, and technologies like SmartCube® help create new drugs.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.

Terbinafine is the most effective medicine for fungal nail infections, especially for diabetics and those with weak immune systems.

Proxalutamide improved recovery, lowered death rates, and reduced hospital stay for COVID-19 patients.

Topical therapies show promise for hair loss and acne treatment with minimal side effects.

Laser treatment and deroofing are effective options for hidradenitis suppurativa.

Erectile dysfunction is increasingly common in men under 40, with many physical and psychological causes, and various treatment options available.

JAK inhibitors show promise for treating various skin diseases.

New treatments for COVID-19 show promise, but more effective antiviral drugs are needed.

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

The Middle East and Africa need better data, treatment consensus, and support for Alopecia Areata.

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

JAK inhibitors help hair regrowth in alopecia areata but have a high risk of side effects.

Most drugs fail to reach the market, but understanding their properties and using strategies like early toxicity tests and drug repurposing can help advance their development.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.